Justin Gatwood, PhD, MPH^1*, Anthony Masaquel, PhD, MPH^2*, Ryan Ross, MS^3*, Danny Sheinson, PhD^2*, Farah Hossain, PharmD^2*, Jia Li, PhD^2*, Cameron James, PharmD^2* and David Fox, PharmD^2*

¹College of Pharmacy, The University of Tennessee Health Science Center, Memphis, TN
²Genentech, Inc., South San Francisco, CA
³Genesis Research LLC, Hoboken, NJ

Dima El-Sharkawi, MBBS, PhD, FRCPath, MA, MRCP^1,2*, Tasneem Elnafie^3*, Sarah Thompson^3*, Louise Stanton^4*, Nicholas Counsell, MSc^5*, Amit Sud, MD, PhD, FRCPath, MRCP^6,7, Ian Chau, MD^3*, Bhupinder Sharma, MBBS, BSc(Hons) BM FRCR^1,8*, Peter Johnson, MD, FRCP^9,10, David C. Linch^11*, Sunil Iyengar^1,12*, Andrew Davies^13* and David Cunningham, MD, FRCP, FMedSci^1,14*

¹The Institute of Cancer Research (ICR), London, UK, London, United Kingdom
²The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom
³The Royal Marsden NHS Foundation Trust, London, United Kingdom
⁴University of Southampton, Southampton, ENG, GBR
⁵Cancer Research UK and UCL Cancer Trials Centre, UCL Cancer Institute, London, United Kingdom
⁶Royal Marsden Hospital, Sutton, United Kingdom
⁷Institute of Cancer Research, Sutton, GBR
⁸The Royal Marsden NHS Foundation Trust, London, UK, London, United Kingdom
⁹Cancer Research UK Clinical Centre, University of Southampton, Southampton, United Kingdom
¹⁰Southampton General Hospital School of Medicine, Southampton, United Kingdom
¹¹University College London, London, United Kingdom
¹²Royal Marsden Hospital, London, United Kingdom
¹³NCRI/Cancer Research UK Experimental Cancer Medicines Centre, University of Southampton, Faculty of Medicine, Southampton, United Kingdom
¹⁴Royal Marsden Hospital, NHS Foundation Trust, London, United Kingdom

Kelsey H. Natsuhara, MD¹, Chiung-Yu Huang, PhD^2*, Jennifer Knoche, BSN, RN^1*, Shagun Arora, MD¹, Alfred Chung, MD¹, Thomas Martin, MD¹, Jeffrey L. Wolf, MD¹, Sandy W. Wong, MD¹, Nina Shah, MD¹ and Rahul Banerjee, MD³

¹Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA
²Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA
³Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA

Alex Hoover, MD¹, Paige Reimche, MS^2*, Dave Watson, PhD^2*, Mike Finch, PhD^2*, Laura Gilchrist, PhD^2*, Lynn Tanner, PT^2*, Yoav H. Messinger, MD² and Lucie M Turcotte, MD¹

¹Division of Pediatric Hematology/Oncology, University of Minnesota, Minneapolis, MN
²Children's Hospitals and Clinics of Minnesota, Minneapolis, MN

Christopher T Su, MD, MPH¹, Jason Chen, MD² and Jeremy Sussman, MD, MS^2*

¹University of Michigan, Seattle, WA
²VA Ann Arbor Healthcare System, Ann Arbor, MI

Laurie K Pearson, MD¹, Anita J Kumar, MD, PhD², John B Wong, MD^3*, Jonathan W. Friedberg, MD, MMSc⁴, Amy LeClair, PhD, MPhil^5* and Susan K. Parsons, MD, MRCP⁶

¹Division of Hematology and Oncology, Tufts Medical Center, Boston, MA
²Institute for Clinical Research & Health Policy Studies, Tufts Medical Center, Boston, MA
³Division of Clinical Decision Making, Tufts Medical Center, Boston, MA
⁴James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY
⁵Tufts University School of Medicine, Boston, MA
⁶Tufts Medical Center, Tufts University School of Medicine, Boston, MA

Peter Borchmann¹, Michael Papadimitrious^2*, Sybille Riou^2*, Joerg Mahlich^2* and Barbara Werner^3*

¹Cologne Lymphoma Working Group, Department of Internal Medicine I, University Hospital of Cologne, Koeln, Germany
²Miltenyi Biomedicine GmbH, Bergisch Gladbach, Germany
³Team Gesundheit Gesellschaft für Gesundheitsmanagement mbH, Essen, Germany

Mahek Garg, PhD^1*, Ambika Satija, ScD^2*, Yan Song, PhD^3*, Eric Sarpong, PhD^4*, Ben Meade, BA^5*, Esteban Lemus-Wirtz, BA^6*, Katherine Gaburo, BA^2*, James E. Signorovitch, PhD^7*, Monika Raut, MS, PhD^1*, Katherine Elizabeth Ryland, PhD⁸ and Samhita Chakraborty, MD⁹

¹Center for Observational and Real-World Evidence, Merck & Co., Inc., Rahway, NJ
²Analysis Group, Inc., Boston, MA
³Analysis Group, Boston, MA
⁴Merck & Co., Inc., Rahway, NJ
⁵Analysis Group, Inc., Paris, France
⁶Analysis Group, Inc., Boston
⁷Analysis Group Inc., Boston, MA
⁸Merck & Co., Inc., Kenilworth, NJ
⁹Merck & Co., Inc., Chatham, NJ

Neel S. Bhatt, MBBS, MPH^1,2, Kelly J. Shipman, MS^3*, Abby R. Rosenberg, MD, MS, MA^1,3,4*, Kari M. Jenssen^2*, K. Scott Baker, MD, MS^1,2, Sheri A. Ballard, MPH^2* and Krysta S. Barton, PhD^3*

¹Department of Pediatrics, Division of Hematology/Oncology, University of Washington School of Medicine, Seattle, WA
²Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
³Seattle Children's Research Institute, Palliative Care and Resilience Program, Seattle, WA
⁴Cambia Palliative Care Center of Excellence, University of Washington, Seattle, WA

Joaquin Martinez Lopez^1*, Javier De La Cruz^2*, Rodrigo Gil-Manso^3*, Celina Benavente Cuesta^4*, Lauren Benito, MD^5*, jose Angel Hernandez, MD^6*, Maria Regina Herraez^7*, Pilar Herrera Puente^8*, Mi Kwon, MD, PhD^9*, Keina Quiroz, MD^10*, Andres Arroyo, Ph^11*, Adrian Alegre, MD, PhD¹², María Pilar Llamas Sillero, MD, PhD^13*, Javier López Jiménez, MD, PhD^14*, Pedro Sanchez-Godoy, MD^15*, Rafael F. Duarte, MD, PhD, FRCP¹⁶, Jose L. Diez Martin, MD PhD^17*, Víctor Jiménez-Yuste, MD, PhD^18* and Julio Garcia-Suarez^19*

¹Hospital 12 De Octubre, Complutense University, CNIO, Madrid, Spain
²Hospital Universitario 12 De Octubre, Instituto De Investigación Sanitaria, Madrid, Spain
³Hematology Department, Hospital 12 de Octubre, Madrid, Spain
⁴Department of Haematology, Hospital Clínico San Carlos. Madrid, Spain, Madrid, ESP
⁵Hematology Department, Hospital Universitario de Getafe, Madrid, Spain
⁶Hospital Universitario Infanta Leonor, Madrid, Spain
⁷SERMAS, MAdrid, Spain
⁸Hematology and Hemotherapy, Hospital Universitario Ramón y Cajal, Madrid, Spain
⁹Department of Hematology, Hospital General Universitario Gregorio Marañón, Gregorio Marañon Health Research Institute, Madrid, Spain
¹⁰Hospital de Mostoles, Mostoles, Spain
¹¹Department of Biochemestry, Complutense University, i+12, Madrid, Spain
¹²Department of Hematology, Univeritary Hospital La Princesa, Madrid, Madrid, Spain
¹³Hospital Universitario Fundacion Jimenez Diaz - IISFJD-UAM, Madrid, Spain
¹⁴Hematology Service, Hospital Universitario Ramón y Cajal, Madrid, Spain
¹⁵Hematology Department, Hospital Universitario Severo Ochoa, Madrid, Spain
¹⁶Hematology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain
¹⁷Department of Medicine, School of Medicine, Complutense University of Madrid, Madrid, Spain
¹⁸Hospital Universitario La Paz, Madrid, Spain
¹⁹Hospital Universitario Principe de Asturias, Alcala De Henares, ESP

Olufunmilayo A Bamigbola, MBBS, MSc (Epid)^1*, Cherie D Bates, MA^2* and Lorna E Warwick, BA, B Ed^3*

¹Research, Lymphoma Coalition, Mississauga, ON, Canada
²Research Department, Lymphoma Coalition, Kelowna, BC, Canada
³Management, Lymphoma Coalition, Mississauga, ON, Canada

Aaron S Rosenberg, MD¹, Albert William Riedl^2*, Michelle A. Quan, MD³, Kwan-Keat Ang, MD^3*, Joseph M Tuscano, MD^1,4, Naseem S Esteghamat, MD¹, Brian A. Jonas, MD, PhD⁵, John Graff^6*, Matthew Renquist^2*, Joseph Cawood^2*, Jeanna L Welborn, MD⁷, Rasmus T Hoeg, MD^1*, Paul R. Kaesberg, MD⁷, Kent Anderson^2*, Jason Y Adams, MD^8* and Theresa H.M. Keegan, PhD⁹

¹Department of Internal Medicine, Division of Cellular Therapy, Bone Marrow Transplantation and Malignant Hematology, University of California Davis School of Medicine, Sacramento, CA
²Department of Innovation Technology, Cancer Center Data Informatics Integration Initiative (CDI3), University of California, Davis, Sacramento, CA
³Department of Internal Medicine, University of California Davis School of Medicine, Sacramento, CA
⁴Veterans Administration Northern California Health Care System, Sacramento, CA
⁵Department of Internal Medicine, Division of Malignant Hematology, Transplantation and Cellular Therapy, University of California Davis School of Medicine, Sacramento, CA
⁶Department of Pathology and Laboratory Medicine, UC Davis School of Medicine, Sacramento, CA
⁷Department of Internal Medicine, Division of Hematology and Oncology, University of California Davis School of Medicine, Sacramento, CA
⁸Department of Internal Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, University of California, Davis, Sacramento, CA
⁹Center for Oncology Hematology Outcomes Research and Training (COHORT), Division of Hematology and Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA

Peter Borchmann¹, Michael S Papadimitrious, PhD^2*, Joerg Mahlich^2*, Sybille Riou^2* and Barbara Werner^3*

¹Cologne Lymphoma Working Group, Department of Internal Medicine I, University Hospital of Cologne, Koeln, Germany
²Miltenyi Biomedicine GmbH, Bergisch Gladbach, Germany
³Team Gesundheit Gesellschaft für Gesundheitsmanagement mbH, Essen, Germany

Constantine S. Tam^1*, Javier Pinilla Ibarz, MD², Volkan Karakus, MD^3*, Catherine Moura^4*, Miguel Arturo Pavlovsky⁵, Fernando Nicolás Piotrowsky^6*, Martin Šimkovič^7*, Andrew Smith^8* and Stephan Stilgenbauer, MD⁹

¹Peter MacCallum Cancer Centre, Royal Melbourne Hospital, University of Melbourne, Melbourne, VIC, Australia
²Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
³Department of Hematology, Antalya Research and training Hospital, Istanbul, Turkey
⁴ABRALE (Associação Brasileira de Linfoma e Leucemia), São Paulo, Brazil
⁵FUNDALEU, Clinical research center Buenos Aires, Buenos Aires, Argentina
⁶ALMA (Asociación Leucemia Mieloide Argentina), Buenos Aires, Argentina
⁷Department of Internal Medicine - Haematology, University Hospital and Medical School, Hradec Kralove, Czech Republic
⁸Leukaemia Foundation, Brisbane, Australia
⁹Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany

Nina Samuel, BA¹, Lauren Laufer, MS, BA¹, Rodrigo Tanaguchi, MD^2*, Joel Rosiene, MD^2*, Carlo Palesi^3*, Richard Elkind, PA-C, MS⁴, Ioannis Mantzaris, MD⁵, Aditi Shastri, MD⁶, Noah Kornblum, MD^7*, R. Alejandro Sica, MD⁸, Urvi A Shah, MD⁹, Dennis Cooper, MD⁴, Amit Verma, MD, MBBS^10* and Nishi Shah, MD, MPH⁷

¹Albert Einstein College of Medicine, Bronx, NY
²Montefiore Medical Center, Bronx, NY
³Department of Pathology, Montefiore Medical Center, Bronx, NY
⁴Department of Oncology, Montefiore Medical Center/ Albert Einstein College of Medicine, Bronx, NY
⁵Department of Hematology and Medical Oncology, Montefiore Medical Center Center for Cancer Care, New York, NY
⁶Oncology, Hematology/Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
⁷Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
⁸Department of Hematology and Medical Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
⁹Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁰Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY

Scott F. Huntington, MD, MPH¹, Enrico De Nigris^2*, Justin Puckett, BA^3*, Sachin Kamal-Bahl, PhD^4*, Mohammed Z.H. Farooqui, DO², Katherine Elizabeth Ryland, PhD⁵, Eric Sarpong, PhD^2*, Xiaoqin Yang, PhD^2* and Jalpa Doshi, PhD^6*

¹Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT
²Merck & Co., Inc., Rahway, NJ
³COVIA Health Solutions, Philadelphia, PA
⁴COVIA Health Solutions, Lansdale, PA
⁵Merck & Co., Inc., Kenilworth, NJ
⁶Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

Sikander Ailawadhi^1,2, Jay R. Hydren, PhD^3*, Leyla Bojanini^4*, Nathan W. Sweeney, PhD³, Felicia Seng^5*, Mizba Baksh^6*, Ahsan Rasheed^6*, Mays Abdulazeez, MBBS, MD^6*, Meghna Ailawadhi, MD^6*, Keren George, MD^7*, Ricardo D Parrondo, MD⁶, Vivek Roy, MD⁶, Victoria R. Alegria^6*, Pooja Advani^6*, Rami Manochakian, MD^6*, Jason S. Starr, DO^6*, Taimur Sher, MD⁸, Jennifer M. Ahlstrom, BA^3* and Asher Chanan-Khan, MD⁶

¹Department of Cancer Biology, Mayo Clinic, Jacksonville, FL
²Division of Hematology/Oncology, Department of Medicine, Mayo Clinic, Jacksonville, FL
³HealthTree Foundation, Lehi, UT
⁴Division of Hematology-Oncology, Stanford School of Medicine, Stanford, CA
⁵Healthtree Foundation, Lehi, UT
⁶Division of Hematology-Oncology, Mayo Clinic, Jacksonville, FL
⁷Division of Hematology-Oncology, Mayo Clinic, Jacksonville
⁸Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL

Chijioke Nze, MD, MPH¹, Clark R Andersen, MS^2*, Amy Ayers, MPH^1*, Jason Westin, MD³, Michael L. Wang, MD¹, Swaminathan P. Iyer, MD¹, Sairah Ahmed, MD^1,3, Chelsea C. Pinnix, MD, PhD⁴, Francisco Vega, MD, PhD⁵, Lorna McNeil, PhD MPH^6*, Lynne Nguyen^3*, Loretta J. Nastoupil, MD⁷ and Christopher R. Flowers, MD⁷

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
³The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Health Disparities Research, University of Texas M.D. Anderson Cancer Center, Houston
⁷Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX